A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

It doesn’t open up the tapestry of human experience — it reads like it was written by a shut-in with Wi-Fi and a thesaurus.

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

The Gates Foundation rings the alarm on the century’s first reversal in progress to save the world’s poorest children, ...

An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals ...

As of the November 30, 2025 data cutoff, two patients with non-Hodgkin's lymphoma had completed multiple GT801 administrations without lymphodepleting chemotherapy, demonstrating the feasibility of ...

Talent development expert Liz Wiseman tells us how principals can bring out the best in everyone on their staff—and avoid ...

"Implementing CSA for GxP Systems - Transition, Documentation, and Post-Transition Challenges and Opportunities" training has been added to ResearchAndMarkets.com's offering. The transition to ...

It doesn’t open up the tapestry of human experience — it reads like it was written by a shut-in with Wi-Fi and a thesaurus.

Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific antibody, and multiple antibody-drug conjugates (ADCs), generating clinical ...

Korea power firms race to localize HVDC for West Coast energy expressway Korean firms scramble to localize HVDC tech through ...

Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific antibody, and multiple ...